China News Service, Beijing, March 11 (Reporter Song Yusheng, Gong Hongyu, Wu Jiaju, Zhang Ni) "Accelerate the development of new productive forces" and "Actively cultivate emerging industries and future industries"... In the National Two Sessions, the outside world observes China's policy trends and economic trends. As an important window, "new" has undoubtedly become a bright word. How do foreign companies view these "new" that are closely related to technological innovation?
Foreign companies are hotly discussing China’s innovation prospects
"Technology is developing at a rapid pace. Since last year, generative artificial intelligence technology has brought many disruptive innovations." Huang Zhiming, Cisco's global vice president and CEO of Greater China, said that we sincerely agree with the Chinese government's "Artificial Intelligence +" action, Digital transformation actions in manufacturing, and rapid decision-making and investment in digital infrastructure.
Foreign companies in different industries also have similar observations on China’s innovation prospects.
Huo Yansi, general manager of Lundbeck China, said, “In the past few years, we have witnessed China’s increasingly improved policy environment, strong innovation momentum, and investment in cultivating high-quality medical talents, all of which have driven the innovation and upgrading of the pharmaceutical industry. "
"Innovation is crucial to the pharmaceutical industry." As a senior executive of a pharmaceutical company, Mo Ancen, President of UCB China, was "deeply excited" that "innovative drugs" were included in the government work report for the first time.
In his view, this decision shows that China attaches great importance to the field of innovation.
“This also makes me pay close attention to the frontier medical fields such as digital health, artificial intelligence and smart medicine, hoping to gain a deeper understanding of how policies work together to promote stronger innovation cooperation.”
Mo Anzen said that he looks forward to witnessing the emergence of more innovative results originating from China and benefiting the world in the future, bringing more substantive pharmaceutical innovations to the world.
This will also inject new momentum into the early realization of UCB's strategic goal of "China for China, China for the world" in China's new development stage.
What are the innovation advantages of China in the eyes of foreign companies?
Foreign-funded enterprises are optimistic about China's innovation capabilities, which has its own internal logic.
Mo Anzen pointed out that the most fundamental driving force of innovation lies in people.
Today, China has abundant intellectual resources, which provide key support for the rise of new productive forces.
Taking the field of medicine and health as an example, he pointed out that China has accumulated a strong team of professionals in the field of medicine and health, including a large number of experts, scientific researchers and practicing physicians.
The existence of this large team has promoted medical innovation and the rapid development of the pharmaceutical industry.
Thousands of medical schools and research institutions in China are actively involved in new drug discovery and clinical trials, providing strong support for the industry's technical foundation.
In addition, China also has abundant medical data resources, and the scale of medical big data is huge, providing important information for medical research and development.
Wang Qian, general manager of LinkedIn China, also said frankly that we have also witnessed the return of many top overseas talents. They bring with them rich experience and innovative thinking to inject new vitality into China's business innovation.
In an interview with a reporter from Sino-Singapore Finance, Thermo Fisher China President Feng Shihan pointed out that he pays attention to and fully recognizes China’s emphasis on technological innovation and talent cultivation emphasized in the Chinese government work report.
In addition to intellectual resources, the Chinese government's policy support and China's progress in big data, cloud computing, artificial intelligence and other fields have injected strong impetus into improving technological innovation capabilities.
Many foreign company executives interviewed mentioned that the current vigorous development of China's innovation ecosystem has created new opportunities for multinational companies, helping to achieve higher-quality development in China and around the world.
Foreign companies take practical actions to participate in China’s innovation process
Many foreign companies have stated that they will participate in China's innovation process with practical actions.
GE Healthcare has made it clear that it will double its R&D investment in China in the next three years, accelerate the output of innovative results, and will continue to connect China with the world's top universities and scientific research institutions, focusing on the two main lines of energy efficiency to promote new productivity. in clinical practice.
Wang Qi said that LinkedIn will continue to deepen the research and development and application of big data and artificial intelligence technology, strengthen cooperation with governments, enterprises and all sectors of society, and jointly promote the development of digital industry clusters.
We will actively participate in the "artificial intelligence +" action, explore more innovative application scenarios, and provide more intelligent and convenient services for enterprises and talents.
Akihiro Fukaishi, chairman and president of Epson (China) Co., Ltd., said that the company will continue to gain insight into the Chinese local market, take the concept of "saving, small and precise" as the basis for continuous innovation, insist on excellence in products and technologies, adjust business models, and strengthen Cooperate with Chinese partners to launch products and services tailored for the Chinese market, and jointly support the digital transformation of the industry.
Bai Ruiming, chief commercial officer of Rio Tinto Group, said that the company established the China Technology and Innovation Center in Beijing to better connect China's leading research, technology and innovation capabilities and provide solutions to Rio Tinto's global operational and strategic challenges.
(over)